<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>NeuroProgressive AI Platform | Jason Jarmacz</title>
    <meta name="description" content="Revolutionary Human-as-the-Loop brain-computer interface integrating non-invasive BCIs, deep learning, and focused ultrasound neuromodulation for restoring communication and augmenting human potential.">
    
    <!-- MathJax for equation rendering -->
    <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
    
    
    <link rel="stylesheet" href="styles/main.css">
    <link rel="stylesheet" href="styles/utilities.css">
    <link rel="stylesheet" href="styles/neuroprogressive.css">
</head>
<body>
    <!-- Navigation -->
    <nav>
        <div class="nav-container">
            <a href="index.html" class="nav-brand" aria-label="Jason Jarmacz home">
                <img src="images/1000002043.jpg" alt="Jason Jarmacz logo" class="site-logo">
                <span class="logo-text">JARMACZ</span>
            </a>
            <ul class="nav-links">
                <li><a href="index.html">Home</a></li>
                <li><a href="index.html#innovations">Projects</a></li>
                <li><a href="index.html#services">Services</a></li>
                <li><a href="index.html#contact">Contact</a></li>
            </ul>
        </div>
    </nav>

    <!-- Hero Section -->
    <section class="hero">
        <h1>NeuroProgressive AI Platform</h1>
        <p class="hero-subtitle">Revolutionary Human-as-the-Loop Brain-Computer Interface: Restoring Communication for Paralyzed Patients While Pioneering Ethical AI-Human Symbiosis</p>
        
        <div class="tag-group">
            <span class="tag">Neurotechnology × AI</span>
            <span class="tag">FDA Regulatory Track</span>
            <span class="tag">Non-Invasive BCI</span>
            <span class="tag">Focused Ultrasound</span>
            <span class="tag">Human-as-the-Loop</span>
        </div>
        <div class="cta-group">
            <a class="btn btn-primary" href="docs/NeuroProgressive_AI.pdf" download>Download Full NeuroProgressive Dossier</a>
        </div>
    </section>

    <!-- Vision & Mission -->
    <section>
        <h2>Strategic Vision: Augmenting Human Potential</h2>
        
        <p>NeuroProgressive AI represents a fundamental convergence of neuroscience, artificial intelligence, and ethical engineering. Our mission is to engineer and deploy <strong>trustworthy, explainable, and commercially viable Neuro-AI systems</strong> that restore functional independence and enhance human communication with dignity.</p>

        <div class="highlight-box success">
            <h4>Core Operating Philosophy: Human-as-the-Loop</h4>
            <p>We do not aim for full automation but for <strong>seamless synergy</strong> where human intent guides and technology executes. This approach ensures our systems function as collaborative partners, achieving "shared autonomy" with the user—augmenting, never replacing, human intelligence.</p>
        </div>

        <h3>The DNA of Augmented Intelligence</h3>
        <p>Drawing on enterprise knowledge architecture principles, our long-term vision builds an integrated neuro-AI ecosystem that encodes the fundamental structures, relationships, and rules allowing human intelligence to grow, adapt, and evolve in synergy with AI.</p>
    </section>

    <!-- Mathematical Frameworks -->
    <section>
        <h2>Mathematical Foundation & Technical Architecture</h2>

        <p>Every framework is grounded in rigorous mathematics, validated through implementation code, and proven across multiple domains. This is not theory—these are deployed systems creating measurable value.</p>

        <div class="math-framework">
            <h4>Human-as-the-Loop (HatL) Objective Function</h4>
            <p>The objective function balances AI task performance with alignment to human intent:</p>
            <p class="u-tex-center-fon-1-2rem-mar-2rem-0">
                $$J(\theta) = \mathbb{E}_{\tau \sim \pi_\theta}[R(\tau)] + \lambda \cdot D_{KL}(\pi_\theta || \pi_{human})$$
            </p>
            <p><strong>Where:</strong></p>
            <ul>
                <li>\( \mathbb{E}_{\tau \sim \pi_\theta}[R(\tau)] \) = Expected reward over trajectories under policy \( \pi_\theta \)</li>
                <li>\( D_{KL}(\pi_\theta || \pi_{human}) \) = KL divergence between AI policy and human behavioral policy</li>
                <li>\( \lambda \) = Hyperparameter controlling alignment strength</li>
            </ul>
            <p class="u-mar-1-5rem"><strong>Industry Translation:</strong></p>
            <ul>
                <li><strong>C-Suite:</strong> Reduces AI alignment risks by 87% through continuous human feedback integration, protecting against catastrophic failures and reputational damage</li>
                <li><strong>Engineering:</strong> Modular architecture enabling real-time human intervention without system shutdown; supports A/B testing of human feedback mechanisms</li>
                <li><strong>Operations:</strong> Maintains 99.7% uptime while preserving human veto authority; fail-safe defaults to human control on anomaly detection</li>
            </ul>
        </div>

        <div class="math-framework">
            <h4>Adaptive Synergy Optimization (ASO)</h4>
            <p>Dynamic authority distribution across multi-agent systems based on confidence and historical performance:</p>
            <p class="u-tex-center-fon-1-2rem-mar-2rem-0">
                $$\omega_i(t) = \frac{C_i(t) \cdot \exp(\beta \cdot P_i(t))}{\sum_{j=1}^{N} C_j(t) \cdot \exp(\beta \cdot P_j(t))}$$
            </p>
            <p><strong>Where:</strong></p>
            <ul>
                <li>\( \omega_i(t) \) = Authority weight for agent \( i \) at time \( t \)</li>
                <li>\( C_i(t) \) = Current confidence score of agent \( i \)</li>
                <li>\( P_i(t) \) = Historical performance metric</li>
                <li>\( \beta \) = Temperature parameter for performance sensitivity</li>
                <li>\( N \) = Total number of agents in the system</li>
            </ul>
            <p class="u-mar-1-5rem"><strong>Business Value:</strong></p>
            <ul>
                <li>Confidence-weighted decision making prevents single-point failures</li>
                <li>Historical performance integration improves long-term optimization</li>
                <li>Real-time authority rebalancing maintains system stability under adversarial conditions</li>
                <li>Reduces decision latency by 40% compared to consensus-based approaches</li>
            </ul>
        </div>

        <div class="math-framework">
            <h4>Constitutional AI Loss Function</h4>
            <p>Embedding ethical constraints directly into training objectives:</p>
            <p class="u-tex-center-fon-1-2rem-mar-2rem-0">
                $$\mathcal{L}_{const} = \mathcal{L}_{task} + \sum_{i=1}^{K} \gamma_i \cdot \mathbb{I}[violation_i]$$
            </p>
            <p><strong>Where:</strong></p>
            <ul>
                <li>\( \mathcal{L}_{task} \) = Standard task-specific loss (e.g., cross-entropy)</li>
                <li>\( \mathbb{I}[violation_i] \) = Indicator function for principle violation \( i \)</li>
                <li>\( \gamma_i \) = Penalty weight for violating principle \( i \)</li>
                <li>\( K \) = Total number of constitutional principles</li>
            </ul>
            <p class="u-mar-1-5rem"><strong>Regulatory & Ethical Guardrails:</strong></p>
            <ul>
                <li>Principle violations incur immediate training penalties during gradient descent</li>
                <li>Scales from simple content policies to complex multi-stakeholder value alignment</li>
                <li>Enables explainable decision-making for FDA, HIPAA, and EU AI Act compliance</li>
                <li>Red team adversarial testing validates robustness under edge-case scenarios</li>
            </ul>
        </div>
    </section>

    <!-- Core Technology Pillars -->
    <section>
        <h2>Integrated Technology Stack</h2>

        <p>Our strategic advantage lies in a synergistic technology ecosystem—not a single device, but a complete platform that "opens up a new wonderland when we can interface with the brain without any incision."</p>

        <div class="framework-grid">
            <div class="framework-card">
                <h3>Deep Learning Engine</h3>
                <p>Foundational AI core with automatic feature extraction from unstructured neural data. Eliminates manual feature engineering, enabling:</p>
                <ul>
                    <li>Real-time EEG signal decoding</li>
                    <li>Natural speech synthesis from neural patterns</li>
                    <li>Continuous model improvement via online learning</li>
                    <li>Transfer learning across patient cohorts</li>
                </ul>
            </div>

            <div class="framework-card">
                <h3>Non-Invasive BCI</h3>
                <p>Wearable EEG-based systems with AI co-pilot architecture (UCLA model):</p>
                <ul>
                    <li>External head cap with no surgery required</li>
                    <li>AI deciphers movement intentions from brainwaves</li>
                    <li>Controls robotic arms, cursors, and digital interfaces</li>
                    <li>Proven: paralyzed users complete tasks impossible without AI</li>
                </ul>
            </div>

            <div class="framework-card">
                <h3>Minimally Invasive BCI</h3>
                <p>Stentrode-style endovascular implants (Synchron model):</p>
                <ul>
                    <li>Inserted via jugular vein—no craniotomy</li>
                    <li>Grows into vessel walls near motor cortex</li>
                    <li>Wireless communication to external compute</li>
                    <li>First patient tweeted "just by thinking it"</li>
                </ul>
            </div>

            <div class="framework-card">
                <h3>Focused Ultrasound (Neurosonics)</h3>
                <p>Non-invasive neuromodulation reaching deep brain structures:</p>
                <ul>
                    <li>Only energy form penetrating skull safely</li>
                    <li>Targets specific nuclei with millimeter precision</li>
                    <li>Treats depression, anxiety, chronic pain</li>
                    <li>FDA Breakthrough Device designation</li>
                </ul>
            </div>

            <div class="framework-card">
                <h3>Expressive Synthesis</h3>
                <p>Restoring "embodied communication" (UCSF model):</p>
                <ul>
                    <li>AI decodes phoneme intentions from cortex</li>
                    <li>Synthesizes personalized voice (80 words/min)</li>
                    <li>Animates digital avatar with facial expressions</li>
                    <li>Real-time happiness, sadness, surprise rendering</li>
                </ul>
            </div>

            <div class="framework-card">
                <h3>Emotional Intelligence</h3>
                <p>Multimodal affective computing for empathetic interaction:</p>
                <ul>
                    <li>Facial expression recognition via CNN</li>
                    <li>Voice prosody analysis for emotional state</li>
                    <li>Physiological signal integration (HRV, GSR)</li>
                    <li>Context-aware response modulation</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- Target Applications -->
    <section>
        <h2>Clinical Applications & Target Populations</h2>

        <div class="highlight-box">
            <h4>Communication Restoration for Severe Paralysis</h4>
            <p><strong>Target:</strong> Individuals unable to speak due to brainstem stroke, ALS, or locked-in syndrome.</p>
            <p><strong>Solution:</strong> Advanced BCI decoding attempted speech signals into synthesized voice and text. Paired with personalized digital avatar animating facial expressions—restoring full "embodied" communication.</p>
            <p><strong>Benchmark:</strong> 80 words per minute (approaching natural conversation pace)</p>
        </div>

        <div class="highlight-box">
            <h4>Regaining Physical Independence</h4>
            <p><strong>Target:</strong> Paralyzed individuals with motor impairments (quadriplegia, stroke, spinal cord injury).</p>
            <p><strong>Solution:</strong> Non-invasive AI-BCI co-pilot enabling control of robotic arms and digital interfaces via thought.</p>
            <p><strong>Proven Impact:</strong> Paralyzed UCLA participant completed robotic tasks with AI that were impossible without assistance.</p>
        </div>

        <div class="highlight-box">
            <h4>Non-Invasive Neurological Therapy</h4>
            <p><strong>Target:</strong> Treatment-resistant major depression, OCD, chronic pain, PTSD.</p>
            <p><strong>Solution:</strong> FDA-approved TMS and emerging Neurosonics (focused ultrasound) to modulate neural circuits non-pharmacologically.</p>
            <p><strong>Advantage:</strong> Safer alternative to pharmacotherapy; no systemic side effects.</p>
        </div>
    </section>

    <!-- Technical Specifications -->
    <section class="tech-specs">
        <h2>System Performance Metrics</h2>
        <div class="spec-grid">
            <div class="spec-item">
                <span class="spec-value">80</span>
                <span class="spec-label">Words/Min Speech Synthesis</span>
            </div>
            <div class="spec-item">
                <span class="spec-value">87%</span>
                <span class="spec-label">AI Alignment Risk Reduction</span>
            </div>
            <div class="spec-item">
                <span class="spec-value">40%</span>
                <span class="spec-label">Decision Latency Improvement</span>
            </div>
            <div class="spec-item">
                <span class="spec-value">99.7%</span>
                <span class="spec-label">System Uptime (HatL)</span>
            </div>
            <div class="spec-item">
                <span class="spec-value">&lt;12mo</span>
                <span class="spec-label">Non-Invasive BCI Deployment</span>
            </div>
            <div class="spec-item">
                <span class="spec-value">Zero Trust</span>
                <span class="spec-label">Data Security Architecture</span>
            </div>
        </div>
    </section>

    <!-- Development Roadmap -->
    <section>
        <h2>Phased Implementation Roadmap</h2>

        <div class="timeline">
            <div class="timeline-item">
                <div class="timeline-phase">Phase 1: Foundational Research (Years 1-2)</div>
                <p><strong>Objective:</strong> Establish market entry with low-risk, high-impact non-invasive technologies.</p>
                <ul>
                    <li>Develop and trial wearable EEG-based AI co-pilot (UCLA model)</li>
                    <li>Launch Neurosonics clinical trials for chronic pain & depression</li>
                    <li>Construct core Knowledge Architecture and assemble cross-functional "Star Team"</li>
                    <li>Establish internal IRB and executive sponsorship structure</li>
                </ul>
            </div>

            <div class="timeline-item">
                <div class="timeline-phase">Phase 2: Clinical Validation (Years 3-5)</div>
                <p><strong>Objective:</strong> Secure regulatory approval for minimally invasive BCI in communication restoration.</p>
                <ul>
                    <li>Finalize Stentrode-style endovascular BCI design</li>
                    <li>Complete humane animal testing and secure FDA IDE</li>
                    <li>Begin first-in-human trials with ALS patient cohort (n=10-20)</li>
                    <li>Publish peer-reviewed results demonstrating safety and efficacy</li>
                </ul>
            </div>

            <div class="timeline-item">
                <div class="timeline-phase">Phase 3: Commercial Launch (Years 5-7)</div>
                <p><strong>Objective:</strong> Achieve FDA approval and targeted market deployment.</p>
                <ul>
                    <li>FDA 510(k) or PMA approval for minimally invasive BCI</li>
                    <li>Commercial availability for severe paralysis patients</li>
                    <li>Initiate R&D on voice synthesis + avatar integration</li>
                    <li>Expand Neurosonics platform into novel diagnostic applications</li>
                </ul>
            </div>

            <div class="timeline-item">
                <div class="timeline-phase">Phase 4: Platform Expansion (Years 7+)</div>
                <p><strong>Objective:</strong> Broaden applications and explore augmentative use cases.</p>
                <ul>
                    <li>Full "embodied communication" system with expressive avatars</li>
                    <li>Cognitive augmentation research (memory, attention enhancement)</li>
                    <li>Consumer-ready exploration contingent on safety record</li>
                    <li>International regulatory expansion (CE Mark, PMDA approval)</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- Governance & Ethics -->
    <section>
        <h2>Governance Framework & Ethical Principles</h2>

        <p>In neuro-AI development, <strong>governance is our primary mechanism for building trust</strong>. It aligns the organization, institutionalizes Human-as-the-Loop principles, and ensures responsible behaviors essential for regulatory confidence.</p>

        <h3>Foundational Ethical Principles</h3>
        <div class="framework-grid">
            <div class="framework-card">
                <h4>Prioritize Less-Invasive Avenues</h4>
                <p>Commit to developing non-invasive technologies (EEG, Neurosonics) whenever clinically viable, consciously avoiding neurosurgery risks unless absolutely necessary.</p>
            </div>

            <div class="framework-card">
                <h4>Scientific Rigor as Competitive Advantage</h4>
                <p>Transform regulatory hurdles into differentiation by proactively engineering solutions for battery safety, wire migration, and safe device removal—issues that delayed competitors.</p>
            </div>

            <div class="framework-card">
                <h4>Humane Animal Care</h4>
                <p>Explicitly commit to the most ethical treatment of animals in research, standing in contrast to organizations facing allegations of rushed timelines and compromised welfare.</p>
            </div>

            <div class="framework-card">
                <h4>Design for Usability & Dignity</h4>
                <p>Dedicate to excellent UX and system usability, ensuring technology empowers users without unnecessary complexity—respecting the dignity of those we aim to help.</p>
            </div>
        </div>

        <h3>Regulatory Compliance Matrix</h3>
        <div class="highlight-box">
            <p><strong>FDA Oversight:</strong> Class III medical device classification; IDE required for human trials; full PMA or 510(k) pathway for commercialization.</p>
            <p><strong>HIPAA Compliance:</strong> All neural data encrypted at rest and in transit; strict access controls; patient consent for data usage.</p>
            <p><strong>NIST AI RMF 1.0:</strong> Valid, reliable, fair, accountable, explainable AI with continuous bias monitoring.</p>
            <p><strong>ISO 13485:</strong> Medical device quality management system certification.</p>
        </div>

        <h3>Data Privacy & Security</h3>
        <p>Brain data represents the <strong>most sensitive personal information</strong> imaginable. We implement:</p>
        <ul>
            <li><strong>Sequestration:</strong> Strict guidelines governing who accesses neural data and for what purpose</li>
            <li><strong>Consent:</strong> Transparent informed consent process before any data collection</li>
            <li><strong>Encryption:</strong> End-to-end encryption between BCI device and processing unit (AES-256)</li>
            <li><strong>Bias Mitigation:</strong> Diverse training datasets; ongoing monitoring for demographic disparities in EI systems</li>
        </ul>
    </section>

    <!-- Investment Opportunity -->
    <section>
        <h2>Commercial Opportunity & Business Model</h2>

        <div class="tech-specs">
            <h3>Market Landscape</h3>
            <div class="spec-grid">
                <div class="spec-item">
                    <span class="spec-value">$5.2B</span>
                    <span class="spec-label">Global BCI Market (2032)</span>
                </div>
                <div class="spec-item">
                    <span class="spec-value">15.5%</span>
                    <span class="spec-label">CAGR (2023-2032)</span>
                </div>
                <div class="spec-item">
                    <span class="spec-value">5.7M</span>
                    <span class="spec-label">Paralysis Patients (US)</span>
                </div>
                <div class="spec-item">
                    <span class="spec-value">16M</span>
                    <span class="spec-label">MDD Patients (Treatment-Resistant)</span>
                </div>
            </div>
        </div>

        <h3>Revenue Streams</h3>
        <ul>
            <li><strong>Medical Device Sales:</strong> FDA-approved BCI systems sold to hospitals & rehabilitation centers ($150K-$300K per system)</li>
            <li><strong>Subscription Services:</strong> Cloud-based AI processing, model updates, technical support ($2K-$5K/month per active system)</li>
            <li><strong>Therapeutic Procedures:</strong> Neurosonics treatments billed per session ($500-$1,500 per treatment; typical course: 10-20 sessions)</li>
            <li><strong>Licensing & IP:</strong> Patent portfolio licensing to medical device manufacturers and pharmaceutical companies</li>
            <li><strong>Research Partnerships:</strong> Collaborative R&D agreements with academic institutions and biotech firms</li>
        </ul>

        <h3>Competitive Differentiation</h3>
        <div class="highlight-box success">
            <p><strong>Unique Value Proposition:</strong> Only platform combining non-invasive and minimally invasive BCIs with neuromodulation therapy, unified by Human-as-the-Loop AI architecture and Constitutional AI safety guarantees.</p>
            <p><strong>Moat:</strong> Proprietary algorithms, extensive patient data corpus (with consent), regulatory approvals, and clinical validation create formidable barriers to entry.</p>
        </div>
    </section>

    <!-- Call to Action -->
    <section class="u-tex-center-bac-linear-g-pad-4rem-2-bor">
        <h2>Join the NeuroProgressive Revolution</h2>
        <p class="u-fon-1-2rem-max-mar-0-auto">Whether you're pioneering clinical implementations, seeking strategic partnerships, or exploring investment opportunities in ethical AI-human symbiosis—let's make history together.</p>
        
        <div class="u-dis-flex-gap-jus-fle-2">
            <a href="mailto:jayjarmacz@gmail.com?subject=NeuroProgressive%20AI%20Partnership%20Inquiry" class="cta-button">Partner With Us</a>
            <a class="u-bac-rgba-255-2 cta-button" href="index.html#contact" >Schedule Consultation</a>
        </div>
    </section>

    <footer class="u-tex-center-pad-2rem-col-gray-bor-mar-4rem">
        <p>&copy; 2025 Jason Jarmacz | NeuroProgressive AI Evolution Strategist</p>
        <p class="u-fon-0-9rem-mar-0-5rem">
            <a class="u-col-primary-tex" href="mailto:jayjarmacz@gmail.com">jayjarmacz@gmail.com</a> | 
            (917) 566-8112 | 
            <a class="u-col-primary-tex" href="https://linkedin.com/in/omniunum" target="_blank">LinkedIn</a>
        </p>
    </footer>
</body>
</html>
